Latest Administration News

RocketBoots Limited has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to an administrative oversight during a holdings restructure. The company affirms its compliance policies and has taken steps to prevent future delays.

Elsight Limited has secured a US$460,000 purchase order from a U.S. public safety customer, marking a significant commercial milestone amid accelerating FAA regulations for drone operations beyond visual line of sight.

Lindian Resources reports strong construction progress at its Kangankunde Rare Earths Project in Malawi, highlighted by the arrival of its Komatsu owner-operator mining fleet and advancing infrastructure works.

Neuren Pharmaceuticals has published promising Phase 2 trial results for NNZ-2591 in Phelan-McDermid syndrome, underpinning its ongoing Phase 3 Koala trial recruiting in the US.

Mount Hope Mining Limited has explained the late lodgement of director interest disclosures as an administrative oversight, responding to ASX concerns over potential compliance breaches.

Mineral Commodities Limited has made its CEO role redundant following the appointment of voluntary administrators, signalling deep restructuring ahead.

Adisyn Ltd has successfully demonstrated low-temperature deposition of an sp²-based carbon layer using Atomic Layer Deposition, a milestone independently verified and critical for semiconductor integration.

Nexsen Limited has initiated FDA engagement for its rapid Group B Streptococcus diagnostic sensor, aiming for expedited US market entry, while bolstering its leadership team and scientific credentials.

ChemX Materials Limited has completed its Deed of Company Arrangement and appointed a new board, yet remains suspended from ASX trading while relying on director-related funding. The company is focused on stabilisation and exploring future opportunities.

Embark Early Education Limited has initiated an off-market takeover bid for Mayfield Childcare Limited, offering shareholders a choice between scrip or cash consideration at a significant premium. The bid aims to consolidate operations and expand Embark’s footprint across Australia’s childcare sector.

BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.

Island Pharmaceuticals reports ongoing FDA review of its antiviral Galidesivir, with no adverse feedback received as the regulator takes extra time to finalise guidance.